Daxor (DXR) Corporation announces the opening of a new BVA program at a premier Florida healthcare center in the Tampa Bay region. This expansion integrates Daxor’s innovative blood volume analysis testing across the facility’s inpatient and outpatient care programs, revolutionizing fluid management precision and enhancing treatment outcomes for a spectrum of conditions. The facility will utilize Daxor’s state-of-the-art Tennessee-based CLIA-certified ezBVA Lab that delivers comprehensive blood volume analysis results within 24 hours of sample receipt.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXR:
- Daxor announces expansion of BVA capabilities in three new hospitals
- Daxor to showcase blood volume analysis at Cardiovascular Transforum conference
- Daxor announces new data at ACC on blood volume analysis
- Daxor announces submission of Daxor BVA to FDA
- Daxor announces new data from Duke University on BVA at ACC